Director
DIN: 10216509
Yogesh Harichandra Nimase is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at AY PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10216509.Yogesh Harichandra Nimase has previously been associated with 1 company in roles such as Designated Partner.Yogesh Harichandra Nimase is currently involved in 2 different roles. Their most recent position is with APEX REALTY PROJECTS LLP as a Designated Partner. The first company Yogesh Harichandra Nimase was appointed to as a director was AY PHARMA PRIVATE LIMITED. Yogesh Harichandra Nimase is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Yogesh Harichandra Nimase is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at AY PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10216509.Yogesh Harichandra Nimase has previously been associated with 1 company in roles such as Designated Partner.Yogesh Harichandra Nimase is currently involved in 2 different roles. Their most recent position is with APEX REALTY PROJECTS LLP as a Designated Partner. The first company Yogesh Harichandra Nimase was appointed to as a director was AY PHARMA PRIVATE LIMITED. Yogesh Harichandra Nimase is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
8 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| AY PHARMA PRIVATE LIMITED | Director | 25-Apr-2025 |